First, second and third generation CAR NK cells have been generated, using lentiviral vectors, to target tumor antigens such as CD19 [128,129], CD20 [128], CD33 [130], CD7 [131], CD22 [132], ErbB2 [133] and EGFR [134,135]. This evidence concerns the gene EGFR and neoplasm.